Difluorinated-Curcumin (CDF): A Novel Curcumin Analog is a Potent Inhibitor of Colon Cancer Stem-Like Cells

Author： Kanwar Shailender Yu Yingjie Nautiyal Jyoti Patel Bhaumik Padhye Subhash Sarkar Fazlul Majumdar Adhip

ISSN： 0724-8741

Source： Pharmaceutical Research, Vol.28, Iss.4, 2011-04, pp. : 827-838

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inclusion Complex of Novel Curcumin Analogue CDF and β-Cyclodextrin (1:2) and Its Enhanced In Vivo Anticancer Activity Against Pancreatic Cancer

By Dandawate Prasad Vyas Alok Ahmad Aamir Banerjee Sanjeev Deshpande Jyoti Swamy K. Jamadar Abeda Dumhe-Klaire Anne Padhye Subhash Sarkar Fazlul

Pharmaceutical Research, Vol. 29, Iss. 7, 2012-07 ,pp. : 1775-1786

Springer Publishing Company

Access to resources Recommend Favorite

Curcumin: A Natural Pan-HDAC Inhibitor in Cancer

Current Pharmaceutical Design, Vol. 24, Iss. 2, 2018-04 ,pp. : 123-129

Bentham Science Publishers

Access to resources Recommend Favorite

Curcumin and Curcumin-like Molecules: From Spice to Drugs

Current Medicinal Chemistry, Vol. 21, Iss. 2, 2014-01 ,pp. : 204-222

Bentham Science Publishers

Access to resources Recommend Favorite

Difluorinated Curcumin: A Promising Curcumin Analogue with Improved Anti-Tumor Activity and Pharmacokinetic Profile

Current Pharmaceutical Design, Vol. 22, Iss. 28, 2016-09 ,pp. : 4386-4397

Bentham Science Publishers

Access to resources Recommend Favorite

Curcumin Targets in Inflammation and Cancer

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 15, Iss. 2, 2015-06 ,pp. : 88-96

Bentham Science Publishers

Access to resources Recommend Favorite